Skip to main content
Home
About Journal
Aim and Scope
Editorial Policy
Peer Review Process
Bibliographic Listings
Editorial Board
For Authors
Information for Authors
Article Submission and Charges
Submit Article
Downloads
Contact Us
Pharmacognosy Journal
An Open Access, Peer Reviewed Journal in the field of Pharmacognosy
Search form
Pharmacognosy Journal
Articles In Press
Current Issue
Archives
RSS Feeds
Submit Article
Home
/
Pharmacognosy Journal, Vol 14, Issue 5, Sep-Oct, 2022
/
Vancomycin, Linezolid, and Ceftaroline In vitro Activity Against Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) Isolates
/
Pages that link to Vancomycin, Linezolid, and Ceftaroline In vitro Activity Against Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) Isolates
Pages that link to Vancomycin, Linezolid, and Ceftaroline In vitro Activity Against Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) Isolates
Primary tabs
View
What links here
(active tab)
Cite This Article
Vancouver Style ::
Purwoningsih E, Endraswari PD, Widodo AD.
Vancomycin, Linezolid, and Ceftaroline In vitro Activity Against Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) Isolates
. Pharmacognosy Journal. 2022;14(5):671-674.
BibTex
XML
PDF
(427.8 KB)
No backlinks found.